A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy

Background Liver biopsy is the essential method to diagnose non-alcoholic steatohepatitis (NASH), but histological features of NASH are too subjective to achieve reproducible diagnoses in early stages of disease. We aimed to identify the key histological features of NASH and devise a scoring model f...

Full description

Bibliographic Details
Main Authors:	Kyoungbun Lee, Eun Sun Jung, Eunsil Yu, Yun Kyung Kang, Mee-Yon Cho, Joon Mee Kim, Woo Sung Moon, Jin Sook Jeong, Cheol Keun Park, Jae-Bok Park, Dae Young Kang, Jin Hee Sohn, So-Young Jin
Format:	Article
Language:	English
Published:	Korean Society of Pathologists & the Korean Society for Cytopathology 2020-05-01
Series:	Journal of Pathology and Translational Medicine
Subjects:	non-alcoholic fatty liver disease non-alcoholic steatohepatitis biopsy consensus
Online Access:	http://www.jpatholtm.org/upload/pdf/jptm-2020-03-07.pdf

Similar Items

Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease
by: Eun Sun Jung, et al.
Published: (2016-05-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2020-10-01)

NON-ALCOHOLIC STEATOHEPATITIS IN CHILDREN − A PRACTICAL APPROACH WITH CASE REPORT
by: Ana Šinkovec, et al.
Published: (2021-10-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
by: Daryl Ramai, et al.
Published: (2021-02-01)

Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
by: Yu Junjie, et al.
Published: (2023-01-01)

Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6
by: Akihide Kamiya, et al.
Published: (2022-11-01)

Fermented field water-dropwort (Oenanthe javanica) alleviates diet-induced non-alcoholic steatohepatitis
by: Dong Hun Lee, et al.
Published: (2022-12-01)

Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway
by: Kyung Eun Kim, et al.
Published: (2023-10-01)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
by: Xia Ziqiang, et al.
Published: (2023-01-01)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
by: Alessandro Federico, et al.
Published: (2021-04-01)

Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis
by: Kanehiko Suwa, et al.
Published: (2020-01-01)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
by: Sina Ghandian, et al.
Published: (2022-03-01)

The Neutrophil-to-Lymphocyte Ratio as A Noninvasive Marker in Patients with Biopsy-Proven Non-Alcoholic Steatohepatitis
by: Mehmet Asıl, et al.
Published: (2016-12-01)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
by: Qingfu Zhu, et al.
Published: (2022-07-01)

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
by: D. V. Garbuzenko
Published: (2022-01-01)

Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report
by: Nahum Méndez-Sánchez, MD, PhD, et al.
Published: (2003-10-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Metabolic preconditions for the formation and progression of steatohepatitis of alcoholic, mixed, non-alcoholic aetiology and their comorbidity with obesity and anaemic conditions
by: T. Antofiichuk, et al.
Published: (2023-05-01)

Role of silymarin in the management of deranged liver function in non-alcoholic steatohepatitis: a case report
by: Yeong Yeh Lee, et al.
Published: (2023-01-01)

Progress on cholesterol metabolism and non-alcoholic steatohepatitis
by: LI Xiao-xiao, SHU Xiang-bing, ZHANG Li
Published: (2022-07-01)

Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study
by: Ji Xiong, et al.
Published: (2015-08-01)

Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
by: Hyeok-Hee Lee, et al.
Published: (2020-06-01)

Celecoxib-mediated attenuation of non-alcoholic steatohepatitis is potentially relevant to redistributing the expression of adiponectin receptors in rats
by: Guoying Zhu, et al.
Published: (2022-07-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
by: Stefania De Lorenzo, et al.
Published: (2020-10-01)

Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
by: Jung Gil Park, et al.
Published: (2020-10-01)

The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
by: Osama Hamid, et al.
Published: (2022-09-01)

Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study
by: Jan Håkon Rudolfsen, et al.
Published: (2024-05-01)

Rapid Recovery from Acute Liver Failure Secondary to Pancreatoduodenectomy-Related Non-Alcoholic Steatohepatitis
by: Kazushige Nirei, et al.
Published: (2013-01-01)

Dynamics of Liver Macrophage Subsets in a Novel Mouse Model of Non-Alcoholic Steatohepatitis Using C57BL/6 Mice
by: Nana Makiuchi, et al.
Published: (2023-09-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Single-cell transcriptomics of hepatic stellate cells uncover crucial pathways and key regulators involved in non-alcoholic steatohepatitis
by: Weiwei He, et al.
Published: (2023-01-01)

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
by: Masatoshi Kudo
Published: (2021-07-01)

A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population
by: Qingling Wang, et al.
Published: (2022-06-01)

Current, emerging, and potential therapies for non-alcoholic steatohepatitis
by: Zhen Yang, et al.
Published: (2023-03-01)

Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action
by: Vanessa D. de Mello, et al.
Published: (2017-04-01)

Evaluation of thrombocytopenia in patients with non-alcoholic fatty liver disease without cirrhosis
by: Carine L. Panke, et al.
Published: (2020-01-01)